Similar findings have been reported in human liver specimens suffering from NASH, as evidenced by elevated levels of LC3-II and p62, thus indicating suppression of lipophagy, with the perpetual accumulation of LC3-II and p62 being positively correlated with the severity of the disease [74]. This evidence concerns the gene SQSTM1 and metabolic dysfunction-associated steatohepatitis.